Concord Drugs Ltd. Stock Analysis 538965.BO

Concord Drugs Ltd. engages in the provision of pharmaceutical formulations. The firm's principal activity is to manufacture licensed drugs based on the formulations approved. The firm is focused on developing drug delivery systems, including multiple unit pellet system (MUPS), sustained release, and modified release pellets. The company operates a Current Good Manufacturing Practice (cGMP) contract manufacturing formulation-fill-finish facility, offering a full spectrum of pharmaceutical development and manufacturing services for drug products. The firm's products include pharmaceutical ready to fill pellets, MUPS; tissue bio adhesive; injectables (small volume parenterals); oral solid dosages (tablets); oral solid dosages (capsules); liquid orals, and dry syrup (powder). The company also offers hand sanitizers under the brand name, PROTON SAFE. The company manufactures hand sanitizers on third party basis also. The firm's oral liquid dosage forms include solutions, syrups, and suspensions.